Focused on accelerating patient-centered drug development for novel, breakthrough therapies.
Dr. Harpreet Singh is an industry leading medical Oncologist with extensive global experience in precision medicine and targeted therapeutics, novel trial design, and innovative regulatory initiatives designed to expedite drug approvals. She is an experienced leader with a demonstrated track record in building high performing cross functioning teams, developing and maintaining excellent working relationships with colleagues in academia, industry, and international regulatory bodies. Dr. Singh is scientifically driven, and patient centered, with high academic integrity and a commitment to regulatory standards. She is a dynamic public speaker with strong engagement and moderator skills.
